146 related articles for article (PubMed ID: 38849340)
1. Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target.
Caldi Gomes L; Hänzelmann S; Hausmann F; Khatri R; Oller S; Parvaz M; Tzeplaeff L; Pasetto L; Gebelin M; Ebbing M; Holzapfel C; Columbro SF; Scozzari S; Knöferle J; Cordts I; Demleitner AF; Deschauer M; Dufke C; Sturm M; Zhou Q; Zelina P; Sudria-Lopez E; Haack TB; Streb S; Kuzma-Kozakiewicz M; Edbauer D; Pasterkamp RJ; Laczko E; Rehrauer H; Schlapbach R; Carapito C; Bonetto V; Bonn S; Lingor P
Nat Commun; 2024 Jun; 15(1):4893. PubMed ID: 38849340
[TBL] [Abstract][Full Text] [Related]
2. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
Alrafiah AR
In Vivo; 2018; 32(5):983-998. PubMed ID: 30150420
[TBL] [Abstract][Full Text] [Related]
3. Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis.
De Marco G; Lomartire A; Manera U; Canosa A; Grassano M; Casale F; Fuda G; Salamone P; Rinaudo MT; Colombatto S; Moglia C; Chiò A; Calvo A
Sci Rep; 2022 Jan; 12(1):395. PubMed ID: 35013445
[TBL] [Abstract][Full Text] [Related]
4. Metals in ALS TDP-43 Pathology.
Koski L; Ronnevi C; Berntsson E; Wärmländer SKTS; Roos PM
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830074
[TBL] [Abstract][Full Text] [Related]
5. A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis.
Srinivasan E; Rajasekaran R
J Mol Neurosci; 2020 Nov; 70(11):1742-1770. PubMed ID: 32415434
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of SOD1, C9orf72, TARDBP and FUS genes in ethnically-diverse Malaysian patients with amyotrophic lateral sclerosis (ALS).
Edgar S; Ellis M; Abdul-Aziz NA; Goh KJ; Shahrizaila N; Kennerson ML; Ahmad-Annuar A
Neurobiol Aging; 2021 Dec; 108():200-206. PubMed ID: 34404558
[TBL] [Abstract][Full Text] [Related]
7. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 or FUS-induced misfolded human wild-type SOD1 can propagate intercellularly in a prion-like fashion.
Pokrishevsky E; Grad LI; Cashman NR
Sci Rep; 2016 Mar; 6():22155. PubMed ID: 26926802
[TBL] [Abstract][Full Text] [Related]
9. Genome Wide Analysis Points towards Subtype-Specific Diseases in Different Genetic Forms of Amyotrophic Lateral Sclerosis.
Dash BP; Naumann M; Sterneckert J; Hermann A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967368
[TBL] [Abstract][Full Text] [Related]
10. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
[TBL] [Abstract][Full Text] [Related]
11. Gene Therapy in Amyotrophic Lateral Sclerosis.
Fang T; Je G; Pacut P; Keyhanian K; Gao J; Ghasemi M
Cells; 2022 Jun; 11(13):. PubMed ID: 35805149
[TBL] [Abstract][Full Text] [Related]
12. Genetics of amyotrophic lateral sclerosis: A review.
Mathis S; Goizet C; Soulages A; Vallat JM; Masson GL
J Neurol Sci; 2019 Apr; 399():217-226. PubMed ID: 30870681
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of microRNAs in the pathogenesis of amyotrophic lateral sclerosis.
Akbari Dilmaghani N; Hussen BM; Nateghinia S; Taheri M; Ghafouri-Fard S
Metab Brain Dis; 2021 Jun; 36(5):737-749. PubMed ID: 33604874
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models.
Milani M; Della Valle I; Rossi S; Fabbrizio P; Margotta C; Nardo G; Cozzolino M; D'Ambrosi N; Apolloni S
Neurotherapeutics; 2024 Apr; 21(3):e00346. PubMed ID: 38493058
[TBL] [Abstract][Full Text] [Related]
15. RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis.
Volkening K; Keller BA; Leystra-Lantz C; Strong MJ
J Proteome Res; 2018 Apr; 17(4):1712-1729. PubMed ID: 29513014
[TBL] [Abstract][Full Text] [Related]
16. The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Bose P; Tremblay E; Maios C; Narasimhan V; Armstrong GAB; Liao M; Parker JA; Robitaille R; Wen XY; Barden C; Drapeau P
Neurotherapeutics; 2019 Oct; 16(4):1149-1166. PubMed ID: 31342410
[TBL] [Abstract][Full Text] [Related]
17. Genetic Convergence Brings Clarity to the Enigmatic Red Line in ALS.
Cook C; Petrucelli L
Neuron; 2019 Mar; 101(6):1057-1069. PubMed ID: 30897357
[TBL] [Abstract][Full Text] [Related]
18. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis.
Nowicka N; Juranek J; Juranek JK; Wojtkiewicz J
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31141951
[TBL] [Abstract][Full Text] [Related]
20. ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.
Bayer H; Lang K; Buck E; Higelin J; Barteczko L; Pasquarelli N; Sprissler J; Lucas T; Holzmann K; Demestre M; Lindenberg KS; Danzer KM; Boeckers T; Ludolph AC; Dupuis L; Weydt P; Witting A
Neurobiol Dis; 2017 Jan; 97(Pt A):36-45. PubMed ID: 27818323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
